Investment Plan for Europe: EIB backs German cancer therapy developer MagForce with up to EUR 35m
Patients who suffer from the most aggressive type of brain cancer, glioblastoma, will soon have broader access to a new form of treatment thanks to financing by the European Investment Bank (EIB). The EIB and German medical device company MagForce … read more

